- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Moderna Inc DRC (MRNAm)
Moderna Inc DRC stock price live, this page displays BCBA MRNAm stock exchange data. View the MRNAm premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Moderna Inc DRC real time stock price chart below.
What Is the Moderna Inc DRC Stock Price Today?
The Moderna Inc DRC stock price today is 3,772.50.
What Is the Stock Symbol for Moderna Inc DRC?
The stock symbol for Moderna Inc DRC is "MRNAm."
What Stock Exchange Does Moderna Inc DRC Trade On?
Moderna Inc DRC is listed and trades on the Buenos Aires stock exchange.
Is Moderna Inc DRC a Good Stock to Buy?
Determining whether Moderna Inc DRC—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the MRNAm quote. (ISIN: AR0666228538)
What Is the Moderna Inc DRC Stock Price Today?
The Moderna Inc DRC stock price today is 3,772.50.
What Is the Stock Symbol for Moderna Inc DRC?
The stock symbol for Moderna Inc DRC is "MRNAm."
What Stock Exchange Does Moderna Inc DRC Trade On?
Moderna Inc DRC is listed and trades on the Buenos Aires stock exchange.
Is Moderna Inc DRC a Good Stock to Buy?
Determining whether Moderna Inc DRC—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the MRNAm quote. (ISIN: AR0666228538)
3,772.50
+17.50(+0.47%)
Delayed Data·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
3,722.50
3,772.50
52 wk Range
1,380.00
4,382.50
MRNAm is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
3,722.503,772.50
52 wk Range
1,380.004,382.50
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
MRNAm Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Significant return over the last week
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy
Moderna Inc DRC Company Profile
Moderna, Inc., a biotechnology company, provides messenger RNA medicines in the United States, Europe, and internationally. The company’s respiratory vaccines include spikevax , mNEXSPIKE, mRESVIA, COVID, RSV, seasonal influenza, combination, and pandemic influenza vaccine; latent vaccines comprise cytomegalovirus, epstein-barr virus, and human immunodeficiency virus vaccines; enteric viruses include norovirus; public health vaccines consist of Zika, Nipah, and Mpox vaccines; and bacterial diseases vaccines, such as lyme vaccines. It also provides oncology therapeutics, such as intismeran autogene, cancer antigen therapy, t-cell engager, and cell therapy enhancer; and rare disease products, including propionic and methylmalonic acidemia, and cystic fibrosis. It has strategic alliances and collaborations with Merck & Co., Inc; Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (Europe) Limited; immatics N.V.; Defense Advanced Research Projects Agency; Biomedical Advanced Research and Development Authority; Institute for Life Changing Medicines; The Bill & Melinda Gates Foundation; and OpenAI. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.
Compare MRNAm to Peers and Sector
Metrics to compare | MRNAm | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipMRNAmPeersSector | |
|---|---|---|---|---|
P/E Ratio | −7.0x | −9.1x | −0.6x | |
PEG Ratio | −0.32 | 0.02 | 0.00 | |
Price/Book | 2.3x | 2.8x | 2.6x | |
Price / LTM Sales | 10.1x | 7.0x | 3.3x | |
Upside (Analyst Target) | - | 45.3% | 45.0% | |
Fair Value Upside | Unlock | 0.8% | 5.9% | Unlock |
Earnings
Latest Release
Feb 13, 2026
EPS / Forecast
-2.11 / --
Revenue / Forecast
678.00M / --
People Also Watch
FAQ
What Is the Moderna DRC (MRNAm) Stock Price Today?
The Moderna DRC stock price today is 3,772.50
What Stock Exchange Does Moderna DRC Trade On?
Moderna DRC is listed and trades on the Buenos Aires Stock Exchange.
What Is the Stock Symbol for Moderna DRC?
The stock symbol for Moderna DRC is "MRNAm."
What Is the Moderna DRC Market Cap?
As of today, Moderna DRC market cap is 27.06T.
What Is Moderna DRC's Earnings Per Share (TTM)?
The Moderna DRC EPS (TTM) is -7.25.
From a Technical Analysis Perspective, Is MRNAm a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Moderna DRC Stock Split?
Moderna DRC has split 0 times.
How Many Employees Does Moderna DRC Have?
Moderna DRC has 4700 employees.
What is the current trading status of Moderna DRC (MRNAm)?
As of Feb 23, 2026, Moderna DRC (MRNAm) is trading at a price of 3,772.50, with a previous close of 3,755.00. The stock has fluctuated within a day range of 3,722.50 to 3,772.50, while its 52-week range spans from 1,380.00 to 4,382.50.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.